171 related articles for article (PubMed ID: 25282581)
21. Ultrasound-detected joint inflammation and B cell count: related variables for rituximab-treated RA patients?
Valor L; Martínez-Estupiñán L; Janta I; Nieto JC; Ovalles-Bonilla JG; González-Fernández C; Del Rio T; Hernández-Flórez D; Monteagudo I; López-Longo FJ; Naredo E
Rheumatol Int; 2016 Jun; 36(6):793-7. PubMed ID: 27072348
[TBL] [Abstract][Full Text] [Related]
22. Tenosynovitis in rheumatoid arthritis patients on biologic treatment: involvement and sensitivity to change compared to joint inflammation.
Hammer HB; Kvien TK; Terslev L
Clin Exp Rheumatol; 2017; 35(6):959-965. PubMed ID: 28516887
[TBL] [Abstract][Full Text] [Related]
23. Pain Catastrophizing, Subjective Outcomes, and Inflammatory Assessments Including Ultrasound: Results From a Longitudinal Study of Rheumatoid Arthritis Patients.
Hammer HB; Uhlig T; Kvien TK; Lampa J
Arthritis Care Res (Hoboken); 2018 May; 70(5):703-712. PubMed ID: 28805018
[TBL] [Abstract][Full Text] [Related]
24. Presence of ultrasound subclinical synovitis and increment of serum vascular endothelial growth factor in a patient with rheumatoid arthritis achieved in sustained clinical remission by treatment with adalimumab and methotrexate.
Kawashiri SY; Arima K; Suzuki T; Nakashima Y; Horai Y; Okada A; Tamai M; Nakamura H; Kawakami A
Mod Rheumatol; 2014 Jul; 24(4):681-4. PubMed ID: 24533548
[TBL] [Abstract][Full Text] [Related]
25. Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis.
Hammer HB; Hansen I; Järvinen P; Leirisalo-Repo M; Ziegelasch M; Agular B; Terslev L
Scand J Rheumatol; 2021 Jul; 50(4):262-270. PubMed ID: 33464147
[No Abstract] [Full Text] [Related]
26. The superb microvascular imaging is more sensitive than conventional power Doppler imaging in detection of active synovitis in patients with rheumatoid arthritis.
Lee GY; Kim S; Choi ST; Song JS
Clin Rheumatol; 2019 Sep; 38(9):2613-2620. PubMed ID: 31030360
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patients.
Reiche BE; Ohrndorf S; Feist E; Messerschmidt J; Burmester GR; Backhaus M
Arthritis Care Res (Hoboken); 2014 Feb; 66(2):204-16. PubMed ID: 23925935
[TBL] [Abstract][Full Text] [Related]
28. Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis.
Nordal HH; Fagerhol MK; Halse AK; Hammer HB
Scand J Clin Lab Invest; 2018; 78(1-2):102-108. PubMed ID: 29278951
[TBL] [Abstract][Full Text] [Related]
29. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study.
Døhn UM; Ejbjerg B; Boonen A; Hetland ML; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller JM; Ostergaard M
Ann Rheum Dis; 2011 Feb; 70(2):252-8. PubMed ID: 20980282
[TBL] [Abstract][Full Text] [Related]
30. Etanercept in the treatment of rheumatoid arthritis: clinical follow-up over one year by ultrasonography.
Iagnocco A; Perella C; Naredo E; Meenagh G; Ceccarelli F; Tripodo E; Basili S; Valesini G
Clin Rheumatol; 2008 Apr; 27(4):491-6. PubMed ID: 17952483
[TBL] [Abstract][Full Text] [Related]
31. Deep clinical remission: an optimised target in the management of rheumatoid arthritis? Experience from an ultrasonography study.
Geng Y; Han J; Deng X; Zhang Z
Clin Exp Rheumatol; 2016; 34(4):581-6. PubMed ID: 27050636
[TBL] [Abstract][Full Text] [Related]
32. Positive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint.
Fukae J; Isobe M; Kitano A; Henmi M; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T
Rheumatology (Oxford); 2013 Mar; 52(3):523-8. PubMed ID: 23192908
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis.
Chen YS; Yan W; Geczy CL; Brown MA; Thomas R
Arthritis Res Ther; 2009; 11(2):R39. PubMed ID: 19284577
[TBL] [Abstract][Full Text] [Related]
34. Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers.
Ramírez J; Ruíz-Esquide V; Pomés I; Celis R; Cuervo A; Hernández MV; Pomés J; Pablos JL; Sanmartí R; Cañete JD
Arthritis Res Ther; 2014 Jan; 16(1):R5. PubMed ID: 24398122
[TBL] [Abstract][Full Text] [Related]
35. Serum calprotectin as a marker of ultrasound-detected synovitis in early psoriatic and rheumatoid arthritis: results from a cross-sectional retrospective study.
Sakellariou G; Lombardi G; Vitolo B; Gomarasca M; Faraldi M; Caporali R; Banfi G; Montecucco C
Clin Exp Rheumatol; 2019; 37(3):429-436. PubMed ID: 30299248
[TBL] [Abstract][Full Text] [Related]
36. Ultrasonographic examination of rheumatoid arthritis patients who are free of physical synovitis: power Doppler subclinical synovitis is associated with bone erosion.
Kawashiri SY; Suzuki T; Nakashima Y; Horai Y; Okada A; Iwamoto N; Ichinose K; Tamai M; Arima K; Nakamura H; Origuchi T; Uetani M; Aoyagi K; Eguchi K; Kawakami A
Rheumatology (Oxford); 2014 Mar; 53(3):562-9. PubMed ID: 24319104
[TBL] [Abstract][Full Text] [Related]
37. Measuring inflammation in rheumatoid arthritis with a new clinical and ultrasound index: development and initial validation.
de Agustín JJ; Erra A; Ponce A; Moragues C; Díaz-Torné C; Reina D; Moreno E; Ramírez J; Mateo L; Pujol Busquets M; Moya P; Santo-Panero P; Ros-Expósito S; Narváez J; Sanmartí R; García de Yébenes MJ; Carmona L
Rheumatol Int; 2019 Dec; 39(12):2137-2145. PubMed ID: 31396686
[TBL] [Abstract][Full Text] [Related]
38. Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled.
Kawashiri SY; Fujikawa K; Nishino A; Okada A; Aramaki T; Shimizu T; Umeda M; Fukui S; Suzuki T; Koga T; Iwamoto N; Ichinose K; Tamai M; Mizokami A; Nakamura H; Origuchi T; Ueki Y; Aoyagi K; Maeda T; Kawakami A
Arthritis Res Ther; 2017 May; 19(1):108. PubMed ID: 28545509
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: results from a prospective multicentre study of rheumatoid arthritis.
Dougados M; Jousse-Joulin S; Mistretta F; d'Agostino MA; Backhaus M; Bentin J; Chalès G; Chary-Valckenaere I; Conaghan P; Etchepare F; Gaudin P; Grassi W; van der Heijde D; Sellam J; Naredo E; Szkudlarek M; Wakefield R; Saraux A
Ann Rheum Dis; 2010 May; 69(5):828-33. PubMed ID: 19740905
[TBL] [Abstract][Full Text] [Related]
40. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
Jonsson MK; Sundlisæter NP; Nordal HH; Hammer HB; Aga AB; Olsen IC; Brokstad KA; van der Heijde D; Kvien TK; Fevang BS; Lillegraven S; Haavardsholm EA
Ann Rheum Dis; 2017 Dec; 76(12):2031-2037. PubMed ID: 28814431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
